Difference between revisions of "Brian Ager"
Mira Purska (talk | contribs) |
|||
| (3 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
| − | Prior to being Director General of the European Federation of Pharmaceutical Industries and Associations, he was Director of [[EuropaBio]]. He | + | Prior to being Director General of the [[European Federation of Pharmaceutical Industries and Associations]], he was Director of [[EuropaBio]]. He served with the European Commission’s Directorate General for Science, Research and Development and as a consultant with the OECD. He has worked for ten years in the UK Government’s [[Health and Safety Executive]] firstly as a Specialist Inspector of health and safety and then as Secretary to the UK’s [[Advisory Committee on Genetic Manipulation]]. Before that he held posts at the UK [[Department of Health]] and in a National Health Service hospital as a clinical biochemist.<ref>http://212.3.246.100/Objects/2/Files/BACV.pdf</ref> |
| − | + | ||
| + | ==References== | ||
| + | <references/> | ||
| + | [[Category:Pharma Lobby Groups]] | ||
Latest revision as of 20:22, 14 January 2008
Prior to being Director General of the European Federation of Pharmaceutical Industries and Associations, he was Director of EuropaBio. He served with the European Commission’s Directorate General for Science, Research and Development and as a consultant with the OECD. He has worked for ten years in the UK Government’s Health and Safety Executive firstly as a Specialist Inspector of health and safety and then as Secretary to the UK’s Advisory Committee on Genetic Manipulation. Before that he held posts at the UK Department of Health and in a National Health Service hospital as a clinical biochemist.[1]
